/
Unless the context otherwise requires, all references in this section to the Company, Ginkgo, we, us, or our refer to the business of Ginkgo Bioworks Holdings, Inc. and our subsidiaries. Overview: Our Mission is to Make Biology Easier to Engineer Our mission is to make biology easier to engineer.
The business is unprofitable at the operating level (-185.29% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 25.1% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$179M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$151M
▼ -25.1% YoY
Net Income (TTM)
-$304M
▲ +42.8% YoY
Op. Margin
-201.90%
▲ +61.3pp YoY
ROIC
-25.24%
▲ +11.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$168M
▲ +53.2% YoY
Op. Cash Flow (TTM)
-$166M
▲ +46.5% YoY
Net Debt
$267M
Cash & Equiv.
$144M
5Y CAGR: +17.3%
Continue Research